Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Certara, Inc. (CERT)

Nasdaq Health Care Health Care Technology S&P SmallCap 600
$12.05
-0.13 (-1.07%)
Close of Nov 06, 2026 · end-of-day data
Source: Certara, Inc.'s 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$208.51M$243.53M$286.10M$335.64M$354.34M$385.15M$418.84M
Cost of revenue$79.77M$100.77M$111.62M$132.58M$141.02M$154.52M$161.13M
Gross profit$128.74M$142.76M$174.49M$203.07M$213.31M$230.63M$257.71M
Research & development$11.63M$19.64M$20.38M$28.20M$34.17M$37.10M$41.04M
Operating income$19.61M-$24.42M$13.58M$32.52M-$40.77M-$1.73M$21.02M
Interest expense$28.00M$25.30M$16.84M$17.77M$22.92M$21.52M$19.74M
Pre-tax income-$9.15M-$50.18M-$3.38M$18.75M-$55.14M-$17.18M$7.62M
Income tax-$225.00K-$784.00K$9.89M$4.02M$214.00K-$5.13M$9.21M
Net income-$8.93M-$49.40M-$13.27M$14.73M-$55.36M-$12.05M-$1.59M
EBITDA$22.21M-$21.98M$15.71M$34.25M$15.30M$66.30M$96.18M
EPS (basic)$-0.07$-0.37$-0.09$0.09$-0.35$-0.08$-0.01
EPS (diluted)$-0.07$-0.37$-0.09$0.09$-0.35$-0.08$-0.01
Diluted shares132.41M133.25M149.84M159.35M158.94M160.39M160.39M
Gross margin61.7%58.6%61.0%60.5%60.2%59.9%61.5%
Operating margin9.4%-10.0%4.7%9.7%-11.5%-0.4%5.0%
Net margin-4.3%-20.3%-4.6%4.4%-15.6%-3.1%-0.4%

Balance sheet

fiscal years · USD
Fiscal yearFY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$29.26M$271.38M$185.80M$236.59M$234.95M$179.18M$189.39M
Receivables—$46.40M$60.17M$72.24M$75.41M$90.61M$94.56M
Total current assets—$346.58M$274.73M$342.25M$340.20M$310.85M$315.12M
Goodwill$515.00M$518.59M$703.37M$717.74M$716.33M$757.04M$745.06M
Total assets—$1.27B$1.51B$1.57B$1.56B$1.58B$1.56B
Total current liabilities—$75.34M$92.22M$103.16M$130.02M$146.09M$153.38M
Short-term debt—$4.68M$3.02M$3.02M$3.02M$3.00M$2.96M
Long-term debt—$294.10M$291.75M$289.99M$288.22M$292.43M$290.13M
Total debt—$298.78M$294.77M$293.01M$291.24M$295.43M$293.09M
Total liabilities—$447.27M$469.88M$493.26M$516.30M$516.45M$493.79M
Shareholders' equity$492.05M$822.13M$1.04B$1.08B$1.05B$1.06B$1.06B

Cash flow

fiscal years · USD
Fiscal yearFY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$38.02M$44.81M$60.39M$92.54M$82.75M$80.47M$96.33M
Capital expenditures$2.11M$863.00K$1.14M$1.43M$1.78M$1.62M$1.76M
Free cash flow$35.92M$43.95M$59.24M$91.11M$80.98M$78.84M$94.56M
Investing cash flow-$9.52M-$8.61M-$269.92M-$27.84M-$79.55M-$112.37M-$26.56M
Financing cash flow-$8.49M$208.21M$123.39M-$7.36M-$9.45M-$21.01M-$63.99M
Share buybacks$703.00K$1.08M——$0$0$42.61M
Stock-based compensation$1.69M$64.51M$29.48M$30.34M$28.30M$34.77M$33.08M
Depreciation & amortization$2.60M$2.44M$2.13M$1.73M$56.07M$68.03M$75.16M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.